Guidance
Screening for Down鈥檚 syndrome, Edwards鈥� syndrome and Patau鈥檚 syndrome: non-invasive prenatal testing (NIPT)
Operational guidance to support the offer of NIPT.
Applies to England
Documents
Details
For health care professionals offering non-invasive prenatal testing (NIPT) screening for Down鈥檚 syndrome (T21), Edwards鈥� syndrome (T18) and Patau鈥檚 syndrome (T13).
Includes information on:
- eligibility for NIPT within NHS FASP
- laboratory requirements for NIPT
- blood sampling and transport
- reporting NIPT results
This publication was previously published by Public Health England, which closed on 30 September 2021.
Updates to this page
Published 26 April 2021
Last updated 8 October 2024
show all updates
-
Added clarification that publication was previously published by Public Health England.
-
2.2 North Thames GLH (Health Service Laboratory (HSL)) blood sampling and transport value has changed.
-
Added lower chance result letter templates.
-
Added information about screening safety incidents (section 9).
-
First published.